Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.


Search Results to Jill E Slansky

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Slansky, Jill

Item TypeName
Academic Article Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.
Academic Article Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells.
Academic Article Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity.
Academic Article Elevated tumor-associated antigen expression suppresses variant peptide vaccine responses.
Academic Article TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
Academic Article Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes.
Academic Article Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras.
Academic Article Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases.
Academic Article A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model.
Academic Article Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.
Academic Article Improving T cell responses to modified peptides in tumor vaccines.
Academic Article Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens.
Concept Cancer Vaccines
Academic Article Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.

Search Criteria
  • Cancer Vaccines

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)